EU regulators support pre-pandemic vaccine

February 24, 2008

The European Medicines Agency has recommended the approval of a vaccine designed to help people build immunity against the deadly bird flu virus.

The Wall Street Journal said the vaccine Prepandrix by GlaxoSmithKline is the first designed to be used before an outbreak occurs. The European Commission still must give final approval, the newspaper said Friday.

GlaxoSmithKline said a number of national governments have expressed interest in stockpiling the pre-pandemic H5N1 vaccine. The company said it plans to submit for U.S. Food and Drug Administration approval by the end of the year.

Copyright 2008 by United Press International

Explore further: Scientists find new way to improve MERS vaccines

Related Stories

Scientists find new way to improve MERS vaccines

November 23, 2016

Since the Middle East Respiratory Syndrome (MERS) was identified in 2012, more than 1,800 people have been infected with the virus that causes MERS, and the fatality rate is a concerning 36 percent. There's still no approved ...

Recommended for you

Universal flu vaccine designed by scientists

September 30, 2016

An international team of scientists have designed a new generation of universal flu vaccines to protect against future global pandemics that could kill millions.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.